The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9
Abstract
1. The potential of ketoconazole and sulphaphenazole to inhibit specific P450 enzyme activities (1A2, 2A6, 2B6, 2C9/8, 2C19, 2D6, 2E1, 3A and 4A) was investigated using human liver microsomes. 2. Ketoconazole demonstrated an inhibitory effect on cyclosporine oxidase and testosterone 6 beta-hydroxylase activities, with mean IC50's of 0.19 and 0.22 microM respectively. Ketoconazole inhibition of the other P450 activities investigated was significantly less, as illustrated by IC50's of at least a magnitude higher. 3. Sulphaphenazole was shown to have an inhibitory effect on tolbutamide hydroxylase activity, with a mean IC50 of 0.8 microM in incubations containing 100 microM tolbutamide. Sulphaphenazole (at concentrations of up to 100 microM) did not exhibit any significant inhibition of the other enzyme activities investigated. 4. Ketoconazole and sulphaphenazole are the respective selective inhibitors of P4503A and 2C9. Ketoconazole at 1 microM and sulphaphenazole at 10 microM can be used to establish the involvement of P4503A and 2C9 respectively in oxidative reactions in human liver microsomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Drug Metabolism and Disposition
(2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12259_4 · Cited by 2,515
NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., et al. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.1 · Cited by 1,655
Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., & Mayer, R. T. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90355-7 · Cited by 1,275
Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1
Peter, R., Boecker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., & Yang, C. S. (1990) · Chemical Research in Toxicology · doi:10.1021/tx00018a012 · Cited by 528
Pichard, L., Fabre, I., Fabre, G., Domergue, J., Saint Aubert, B., Mourad, G., & Maurel, P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08600-3 · Cited by 433
The use of ketoconazole as an inhibitor of steroid production
Oates, J. A., Wood, A. J. J., & Sonino, N. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171307 · Cited by 395
The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
Yamano, S., Tatsuno, J., & Gonzalez, F. J. (1990) · Biochemistry · doi:10.1021/bi00457a031 · Cited by 383
Ketoconazole blocks testosterone synthesis
Pont, A. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.12.2137 · Cited by 350
Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s
Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., & Korzekwa, K. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90602-f · Cited by 324
Combalbert, J., Fabre, I., Fabre, G., Dalet, I., Derancourt, J., Cano, J. P., & Maurel, P. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08744-6 · Cited by 306
Ketoconazole Blocks Testosterone Synthesis
Pont, A. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340250097015 · Cited by 296
Wrighton, S. A., Stevens, J. C., Becker, G. W., & Vandenbranden, M. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1506 · Cited by 281
Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene
Guengerich, F. P. (1990) · Chemical Research in Toxicology · doi:10.1021/tx00016a015 · Cited by 279
Ketoconazole: A Review of its Therapeutic Efficacy in Superficial and Systemic Fungal Infections
Heel, R. C., Brogden, R. N., Carmine, A., Morley, P. A., Speight, T. M., & Avery, G. S. (1982) · Drugs · doi:10.2165/00003495-198223010-00001 · Cited by 276
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture
Maurice, M., Pichard, L., Daujat, M., Fabre, I., Joyeux, H., Domergue, J., & Maurel, P. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1371482 · Cited by 262
Clinical Pharmacokinetics of Ketoconazole
Daneshmend, T. K., & Warnock, D. W. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814010-00002 · Cited by 226
Campbell, M. E., Grant, D. M., Inaba, T., & Kalow, W. (1987) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06689-9 · Cited by 208
Tolbutamide hydroxylation by human liver microsomes
Miners, J. O., Smith, K. J., Robson, R. A., McManus, M. E., Veronese, M. E., & Birkett, D. J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90522-9 · Cited by 198
SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS
Korsgaard Christensen, L., Mølholm Hansen, J., & Kristensen, M. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90847-x · Cited by 195
Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
Pan-Zhou, X.-R., Sérée, E., Zhou, X. J., Placidi, M., Maurel, P., Barra, Y., & Rahmani, R. (1993) · PubMed · Cited by 163
Otton, S. V., Crewe, H. K., Lennard, M. S., Tucker, G. T., & Woods, H. F. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20010-6 · Cited by 162
KETOCONAZOLE, CYCLOSPORIN METABOLISM, AND RENAL TRANSPLANTATION
Ferguson, R., Sutherland, D. R., Simmons, R. L., & Najarian, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90851-0 · Cited by 155
Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man
Zanger, U. M., Vilbois, F., Hardwick, J. P., & Meyer, U. (1988) · Biochemistry · doi:10.1021/bi00415a010 · Cited by 146
Brian, W. R., Srivastava, P. K., Umbenhauer, D. R., Lloyd, R. S., & Guengerich, F. P. (1989) · Biochemistry · doi:10.1021/bi00438a014 · Cited by 132
Site-directed mutation studies of human liver cytochrome P -450 isoenzymes in the CYP2C subfamily
Veronese, M., Doecke, C. J., Mackenzie, P. I., McManus, M. E., Miners, J. O., Rees, D. L. P., Gasser, R. B., Meyer, U., & Birkett, D. (1993) · Biochemical Journal · doi:10.1042/bj2890533 · Cited by 131
Berthou, F., Flinois, J.-P., Ratanasavanh, D., Beaune, P. H., Riché, C., & Guillouzo, A. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07190-9 · Cited by 127
Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.
Sheets, J. J., & Mason, J. I. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07769-4 · Cited by 127
Characterisation of theophylline metabolism by human liver microsomes
Robson, R. A., Miners, J. O., Matthews, A., Stupans, I., Meller, D., McManus, M. E., & Birkett, D. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90423-6 · Cited by 119
Back, D., Tjia, J. F., Karbwang, J., & Colbert, J. E. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03359.x · Cited by 112
Drug Interactions that Matter: A Critical Reappraisal
McInnes, G. T., & Brodie, M. J. (1988) · Drugs · doi:10.2165/00003495-198836010-00006 · Cited by 109
Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
Fabre, G., Julian, B., Saint‐Aubert, B., Joyeux, H., & Berger, Y. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08220-0 · Cited by 108
Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
Doecke, C. J., Veronese, M., Pond, S. M., Miners, J. O., Birkett, D., Sansom, L., & McManus, M. E. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05499.x · Cited by 108
In vitro forecasting of drugs which may interfere with the biotransformation of midazolam
Gascon, M.-P., & Dayer, P. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314987 · Cited by 108
Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion
Glynn, A. M., Slaughter, R. L., Brass, C., DʼAmbrosio, R., & Jusko, W. J. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.114 · Cited by 84
First, M. R., SCHROEDER, T. J., Michael, A. T., Hariharan, S., Weiskittel, P. D., & Alexander, J. W. (1993) · Transplantation · doi:10.1097/00007890-199305000-00009 · Cited by 83
Maurice, M., Emiliani, S., Dalet-Beluche, I., Derancourt, J., & Lange, R. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16212.x · Cited by 75
Characterization of the inhibition of P4501A2 by furafylline
Clarke, S. E., Ayrton, A. D., & Chenery, R. J. (1994) · Xenobiotica · doi:10.3109/00498259409043254 · Cited by 74
Self-citationBack, D., Stevenson, P., & Tjia, J. F. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05410.x · Cited by 68
Ketoconazole: A Major Innovation for Treatment of Fungal Disease
Graybill, J. R., & DRUTZ, D. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-921 · Cited by 67
Clarke, S. E., Baldwin, S. J., Bloomer, J. C., Ayrton, A. D., Sozio, R. S., & Chenery, R. J. (1994) · Chemical Research in Toxicology · doi:10.1021/tx00042a018 · Cited by 59
Self-citationDeLuca, J. G., Dysart, G. R., Rasnick, D., & Bradley, M. O. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90436-4 · Cited by 55
Azoles, a48 llylamines and drug metabolism
Back, D. J., Tjia, J., & ABEL, S. M. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00003.x · Cited by 53
McManus, M. E., Miners, J. O., Gregor, D., Stupans, I., & Birkett, D. J. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb06301.x · Cited by 48
Abel, S. M., & Back, D. J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90325-q · Cited by 30
Lauric acid hydroxylase activity and cytochrome P450 IV family proteins in human liver microsomes
Dlrven, H. A. A. M., Peters, J. G. P., Gibson, G. G., Peters, W. H. M., & JONGENEELEN, F. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90524-9 · Cited by 16
Cited by
Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Metadata
- Authors
- Baldwin, S. J., Bloomer, J. C., Smith, G. J., Ayrton, A. D., Clarke, S. E., & Chenery, R. J.
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 1995-01
- Volume
- 25
- Issue
- 3
- Pages
- 261-270
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W2131614625
- Cited by
- 298
- References
- 47
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.